What can we learn from the vaginal mesh story?

Area of Science:

• Urogynecology
• Biomedical Engineering
• Surgical Innovation

Background:

• Vaginal mesh use in prolapse surgery has become a highly controversial and emotive topic in urogynecology.
• The US Food and Drug Administration's 510(k) system facilitated the widespread adoption of these mesh products globally.
• The mesh controversy highlights critical issues beyond the implant itself.

Purpose of the Study:

• To analyze the urogynecology vaginal mesh controversy.
• To identify key lessons learned from the mesh experience.
• To advocate for the application of these lessons to future urogynecological innovations.

Main Methods:

• Review of the urogynecological vaginal mesh controversy.
• Analysis of factors contributing to the controversy.
• Identification of critical lessons for surgical innovation.

Main Results:

• The proliferation of vaginal mesh was enabled by the US Food and Drug Administration 510(k) system.
• Significant controversy arose due to issues related to the mesh.
• The mesh 'story' offers crucial insights into surgical practices and patient care.

Conclusions:

• A thorough understanding of biomechanical properties of tissues and implants is essential.
• Surgical skill, patient selection, and effective communication are paramount.
• High-quality research and robust informed consent processes are vital for all novel treatments in urogynecology and beyond.